This Award Notice opportunity from Department Of Defense was posted on August 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

NAPROXEN TABLETS

Awarded

SPE2D226F3345Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Pharmaceutical Grade Salicylic Acid SupplyThis subcontract involves the supply of high-purity, pharmaceutical-grade salicylic acid to prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The scope of work encompasses the chemical synthesis and purification of the acid to ensure it meets strict pharmaceutical standards for topical medical applications. All deliverables must be accompanied by SDS documentation and hold USP or equivalent pharmaceutical grade certifications. The project is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance of the contract is designated for FPO 09564. Interested parties should note the response deadline of November 16, 2026, for this bulk supply requirement.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

BISMUTH SUBSALICYLATE

Solicitation # SPE2DP-27-T-0266

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply of 300 mcg and 480 mcg Non-Safety SyringesThis subcontract involves the manufacture and supply of pre-filled non-safety syringes containing 300 mcg and 480 mcg medication for prime contractors supporting Department of Veterans Affairs pharmaceutical supply projects. The scope of work includes producing pharmaceutical dosages with unique NDC numbers and providing commercial packaging in both individual units and boxes of ten. Distribution of these labeled syringes is managed through the VA/DoD Pharmaceutical Prime Vendor Programs. The opportunity is associated with NAICS code 325412 and is managed under Nac Pharmaceuticals for the Department of Veterans Affairs, with a response deadline set for December 15, 2026.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Filgrastim Biosimilar (VA-27-00012533)

Solicitation # 36E79727R0001

The Department of Veterans Affairs, through the National Acquisition Center, is soliciting a contract for Filgrastim Biosimilar under solicitation number 36E79727R0001. This procurement is issued in commercial item format in accordance with FAR Part 12 and is managed by point of contact Dov Vysnia. The contract structure consists of an initial one-year period followed by four pre-priced one-year option periods. Distribution of the pharmaceutical products will be handled through the respective Pharmaceutical Prime Vendor Programs of the VA and the Department of Defense. The scope of work requires the provision of non-safety syringes in 300 mcg and 480 mcg dosages, which must be specifically labeled for use by patients or caregivers. Offerors are required to provide a unique NDC number and the exact product name as it appears on the label. Strict labeling guidelines mandate that the contractor's label be the only one on the product, prohibiting the placement of labels over existing ones, though the packaging must allow VA labels to adhere securely on top. Required commercial packaging includes individual syringes and boxes of ten syringes. Proposals must be submitted electronically via SAM.gov by December 15, 2026, at 2:30 PM Central Time.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--Request for Information (RFI) - Specialty â€“ PPV 2028 Amendment 0002 to Extend Response Date from Nov. 16, 2026 to Nov. 30, 2026 at 11AM CT

Solicitation # 36E79727Q0001

The Department of Veterans Affairs, through the OALC Enterprise Procurement Office, has issued a Request for Information regarding the Pharmaceutical Prime Vendor (PPV) 2028 program. The agency is seeking market research to determine the feasibility of integrating Limited Distribution and Closed Distribution Products (CDP) into the PPV scope. These specialty medications are typically high-cost, low-volume items with restricted distribution channels that often require specific clinical justifications, manufacturer-mandated registrations, and specialized safety monitoring. The primary objective is to establish a seamless ordering platform where all Federal Supply Schedule (FSS) items, including those that bypass the physical possession of the prime vendor, are visible and orderable with accurate invoicing and delivery tracking for VA medical centers nationwide. The government is soliciting detailed feedback from industry partners on their ability to coordinate fulfillment with manufacturer-designated specialty distributors and their capacity to provide consistent reporting and reconciliation for these transactions. Potential respondents must provide their company name, point of contact information, UEI, CAGE code, and any applicable socioeconomic designations. Submissions are due by 11 AM Central on November 16, 2026, via email to Karen Ade. This notice is strictly for market research purposes and does not constitute a formal solicitation or a commitment by the government to award a contract.

Nac Prime Vendor (36W797)

POSTED

DEADLINE

Assayed Liquid Human Serum Comprehensive Chemistry Control SupplyThis subcontract involves the supply of assayed liquid human serum-based comprehensive chemistry control for prime contractors supporting Department of Defense DLA Troop Support Medical Supply Chain projects. The requirement is for 84 units of frozen diagnostic control material, specifically Level 3 control featuring over 50 analytes. All materials must have a minimum shelf life of 24 months and be packaged according to Medical Marking Standard No. 1. To ensure product integrity, the contractor must maintain a strict cold chain storage environment between -20 and -70 degrees Celsius. The performance of this contract will take place in APO 09227. This opportunity falls under NAICS code 325412 and is managed by the Medical Supply Chain MD SURG FSF.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Antiseptic Prep Swab SupplierThis subcontract opportunity is for a supplier to manufacture and provide pre-saturated antiseptic swabs to prime contractors supporting Department of Defense medical supply chain projects. The scope of work includes the production of alcohol and Povidone-iodine prep swabs utilizing medical-grade applicators. All products must be individually wrapped, delivered in bulk quantities, and maintain FDA approval for medical-grade antiseptics with a guaranteed stability supporting a 36-month shelf life. Managed by the Medical Supply Chain MD Surg FSF, the contract is associated with NAICS code 325412 and specifies San Antonio as the place of performance. Interested parties must submit their responses by November 16, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Hand Sanitizer (70% Ethyl Alcohol) SupplyThis subcontract involves the supply of unscented, waterless hand cleanser for prime contractors supporting the Department of Defense Medical Supply Chain. The requirement is for four packages of 70% ethyl alcohol base cleanser, with each package containing twenty-four 4 fl oz bottles. All products must adhere to Medical Marking Standard No. 1 and MIL-STD-2073-1E, ensuring a 36-month shelf life with no more than five months elapsed upon delivery. The contract is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance for this contract will take place in Annville, Pennsylvania. Interested parties should note the response deadline of November 16, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Sterile Medical Kitting and PackagingThis subcontract for Sterile Medical Kitting and Packaging supports prime contractors on DLA supply contracts for the Department of Defense Medical Supply Chain. The scope of work involves the assembly of instruments into kits, sterilization for single-use disposable requirements using industrial autoclaves, and final packaging. All deliverables must be marked according to Medical Marking Standard No. 1 and MIL-STD-2073-1E to ensure the delivery of completed, sterile, and sealed Dental Operative Kits. The project falls under NAICS code 325412 and is performed at a facility in FPO 34088-3000. Interested parties should note the response deadline of November 16, 2026, following the posting date of November 8, 2026.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Levonorgestrel and Ethinyl Estradiol Tablets SupplyThis subcontract involves the supply of finished pharmaceutical tablets containing Levonorgestrel and Ethinyl Estradiol for prime contractors supporting Department of Defense DLA Troop Support Medical Supply Chain projects. The contractor is responsible for manufacturing or sourcing tablets that adhere to USP standards, ensuring precise dosage sequencing and a minimum shelf life of 21 months. All production must occur in FDA-approved facilities, and products must be maintained in temperature-controlled storage between 20 and 25 degrees Celsius. Deliverables consist of 168-tablet packages that comply with Medical Marking Standard No. 1A and MIL-STD-129. This opportunity falls under NAICS code 325412 and was posted on November 8, 2026, with a response deadline of November 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Albuterol Sulfate Tablets (4 mg)This subcontract opportunity through the Department of Defense Medical Supply Chain Pharm FSA involves the procurement of 3,000 bottles of Albuterol Sulfate Tablets (4 mg). The selected provider must manufacture or source tablets that strictly adhere to NSN 6505011388028 specifications. To be eligible, candidates must hold status as a qualified pharmaceutical manufacturer or an authorized distributor. The contract mandates the use of commercial packaging and packing standards, specifically requiring sealed unit containers to prevent damage and commercial exterior shipping containers suitable for common carrier delivery. Interested parties must submit their responses by November 16, 2026, under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Veterinary Enrofloxacin Injection SupplierThis subcontract involves the supply of FDA-regulated Enrofloxacin Injection for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The requirement is for 10 units of an intramuscular solution for dogs with a concentration of 2.27 percent and a dosage of 2.5mg/kg in 20ml volumes. All products must be produced in FDA-approved manufacturing facilities and maintain a non-extendable shelf life of 24 months. Strict adherence to Medical Marking Standard No. 1 is required, and the product must be kept in temperature-controlled storage at or below 25 degrees Celsius. The performance location for this contract is listed as APO 09227-0000. Interested parties must respond by November 16, 2026, under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

Defense Logistics Agency award SPE2D226F3345 is a delivery order issued on August 29, 2026, under the base administrative contract SPE2DX25D9822. The contract was awarded to DMS Pharmaceutical Group Inc for the procurement of naproxen tablets, identified by NSN 6505011868758. This specific order consists of two bottles at a unit price of 18.82 dollars, resulting in a total contract price of 37.64 dollars. The overarching base contract, SPE2DX25D9822, was established on March 7, 2025, by the DLA Troop Support Medical Supply Chain FSB with a total award value of 20,000,000.00 dollars. This procurement falls under NAICS code 325412 for pharmaceutical manufacturing. The delivery order includes detailed specifications for shipment, invoicing, and medical substitution as outlined in the associated DD Form 1155 and SF 1449 documentation.

General Info

DLA awarded DMS Pharmaceutical Group 37.64 dollars for Naproxen tablets on August 29, 2026.

Agency

Department Of Defense → Defense Logistics Agency

Contract Value

$37.64

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Awardee

DMS PHARMACEUTICAL GROUP INC

Award Issued Date

08/29/2026, 12:00:00 AM UTC

Documents

3 pages · contract-document

Low

4 pages · contract-document

Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded

PostedAug 29

Award Notice

AwardedAug 29

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Logistics Agency

ContactsNo contacts available

OfficeUSA

Organization / AgencyDepartment Of Defense → Defense Logistics Agency

Office AddressUSA

ContactsNo contact information available

Full Description

DLA award SPE2D226F3345 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $37.64 Award Date: 08-29-2026 Delivery order under: SPE2DX25D9822 Line items: - NAPROXEN TABLETS (NSN/Part 6505011868758, PR 7018116619)